ProductLife Group in Australia

Following the acquisition of Commercial Eyes in 2023, ProductLife Group strengthened its strategic presence in the JAPAC region and expanded its global service capabilities. With more than two decades of experience supporting regulated healthcare products in Australia and New Zealand, Commercial Eyes brings deep regional expertise to the Group. This integration enhances PLG’s ability to support pharmaceutical and MedTech companies across the full product lifecycle, from development through to market and patient access, on a truly global scale.

With a growing number of offices across the JAPAC region, ProductLife Group provides regulatory and safety services to life sciences companies operating in both mature markets including Japan, Australia, New Zealand, South Korea, and Singapore, and emerging markets across Southeast Asia.

Regulatory, Quality & Compliance
Helping your business achieve the optimum commercial outcome for your products.

Market & Patient Access
Delivering strategic insights and competitive intelligence and developing and driving HTA strategy to maximise market opportunities.

Patient Safety & Risk Management
Ensuring patient safety throughout a products lifecycle.

Medical Information
Providing reliable and timely information to healthcare professionals, patients and internal stakeholders.

Patient Programs
Helping you to support patients on their health journey

Sponsorship
Providing Marketing Authorisation Holder (MAH) support in Australia and New Zealand for regulatory approval and ongoing compliance.